| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Biodexa Pharmaceuticals PLCPositive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presen...
https://ppubs.uspto.gov/pubwebapp/external.html?q=(12011445).pn
Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis (FAP) to be Presented at Prestigious Bi...
After the first six months, eRapa appeared to be safe and well-tolerated with a statistically significant 24% reduction (p=0.04...
